Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.05.26.727863

Detecting genomic regions enriched for reciprocal recombination in autism spectrum disorder

Abstract

Meiotic recombination is an important means of increasing genetic diversity by generating novel haplotypes in a population. Recombination separates linked loci extremely slowly in some regions, therefore genetic variants in high linkage disequilibrium may become co-adapted. Reciprocal recombination that separates co-adapted variants may generate a deleterious de novo haplotype that contributes to disease. We developed statistical methods to detect genomic regions of recombination excess in two different family-based study designs. We identified recombination in the Simons Simplex Collection in 273 simplex families with one child with autism spectrum disorder (ASD) and at least two unaffected children, in which recombinations can be mapped to the proband and contrasted with the recombination counts in unaffected siblings; and in 1,802 families with two children, where the number of recombinations identified can be contrasted with the expectation from a reference recombination map. Both strategies revealed a tail of low p-values for loci of interest that contrasted with the rest of the distribution. Permutation and bootstrap tests did not identify genome-wide primary findings in either cohort, but the most significant three-child cohort locus of recombination excess (between cadherin genes CDH4 and CDH26) replicated in the two-child cohort (p=0.01). While this replication strategy was not defined a priori, five of the most recombination enriched bins identified candidate ASD genes (p=0.02; WWOX, ADAMTS16, INSR, ADARB2, and HS6ST1). Since the six identified loci were not identified as regions of high de novo copy number variation in the study cohort and no CNVs were detected in any of the recombinant probands in the identified regions, they represent candidates for reciprocal recombinations generating unfavourable haplotypes for these genes. This study highlights a previously unidentified source of clinical genetic variability contributing to the molecular aetiology of ASD. AUTHOR SUMMARYAutism spectrum disorder (ASD) is a constellation of neurodevelopmental disabilities characterised by deficits in social communication and repetitive patterns of behaviour. While ASD is highly heritable, its genetic basis is complex and poorly understood. While some highly penetrant types of genetic variation have been identified, most people with ASD carry a large number of variants that each contribute a small amount to their overall phenotype. In addition to mutations in individual genes, changes in the configuration of genes along a chromosome may contribute to ASD. Here, we describe a method for identifying regions where such new configurations have occurred through recombination and attempt to find regions where such changes are more common in autistic children than in their non-autistic siblings. We explore recombination as a source of genetic variation contributing to autism, which has potential to inform clinicians in providing services to autistic people and their families.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Mahoney, C. F., Salter-Townshend, M., Fitzpatrick, D. J., Shields, D. C.. 2026-05-27. Detecting genomic regions enriched for reciprocal recombination in autism spectrum disorder. https://doi.org/10.64898/2026.05.26.727863

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Large language model-based bibliometric evaluation of population descriptors in human genetics

As the use of population descriptors such as race, ethnicity, and ancestry have become increasingly common in modern genetics research, there have been growing calls to critically examine their use. Most notably, in 2023, the National Academies of Science, Engineering, and Medicine (NASEM) published a report titled Using Population Descriptors in Genetics and Genomics Research: A New Framework for an Evolving Field, which included eight specific and actionable recommendations for researchers to implement the ethical and accurate use of population descriptors in genetic research. Here, we use the 2023 NASEM report as a benchmark to analyze the use of population descriptors in genome-wide association studies (GWAS). We develop a general toolkit for large language model-based bibliometrics, operationalize the report's recommendations into an evaluation framework, and apply this framework to evaluate all 4,007 papers from the GWAS Catalog published between 2007 and 2025 with full text available on PubMedCentral. We find significant improvements in adherence to NASEM report recommendations over time. However, most improvements predate the publication of the NASEM report itself, suggesting the report functioned primarily as a synthesis of existing best practices rather than a catalyst for change. We conclude by highlighting opportunities for growth in the field of human genetics.

genetics↗

Mitigating biases of rescaling in forward-in-time population genetic simulations

Forward-in-time population genetic simulations are widely used in evolutionary analyses, but simulating large populations and long genomic regions remains computationally demanding. To reduce this cost, parameter rescaling is widely employed, in which the original evolutionary process is approximated by one with a smaller population size and fewer generations. Recently, several studies using the SLiM simulator have raised concerns about the accuracy of this rescaling approach. In this study, we show that many of the biases reported in these studies can be mitigated by using a different simulation algorithm. These results reveal that the accuracy of parameter rescaling depends on how well the simulation algorithm preserves diffusion-limit properties under rescaling.

genetics↗

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗